Anixa Biosciences, Inc.

ANIXNASDAQ • USD
2.65 USD
↗ 0.10 (3.92%)🟢LIVE (AS OF 11:53 AM EST)
🟢Market: OPEN

Anixa Biosciences, Inc. (ANIX) is currently trading at $2.65. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Notable factors include a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place ANIX at a fair price relative to peers.

Technical & fundamental data as of Nov 16, 2026.

Open?$2.55
High?$2.69
Low?$2.55
Prev. Close?$2.55
Volume?74.3K
Avg. Volume?199.9K
VWAP?$2.64
Rel. Volume?0.37x
Bid / Ask
Bid?$2.27 × 100
Ask?$2.67 × 100
Spread?$0.40
Midpoint?$2.47
Valuation & Ratios
Market Cap?88.6M
Shares Out?34.8M
Float?22.5M
Float %?66.1%
P/E Ratio?N/A
P/B Ratio?6.13
EPS?-$0.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
Employees
4
Market Cap
91.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1983-10-07
Address
3150 ALMADEN EXPRESSWAY, SUITE 250
SAN JOSE, CA 95118
Phone: 408-708-9808
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
70
Momentum?
50
Short Sent.?
54
Piotroski F-Score?0/9Weak
Altman Z-Score?2.95Grey
Confidence?48%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?7.24%Elevated
Short Interest?1.6M
Days to Cover?8.4
Free Float22.5M
Avg Daily Volume193.8K
Settlement Date2026-10-30
Financial Health
Current Ratio?8.54Strong
Quick Ratio?8.54Strong
Cash Ratio?0.80Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
30
6.13FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.0CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-71.7%WEAK▾
ROA?
S&P
3
-68.9%WEAK▾
Cash Flow & Enterprise
FCF?$-7376000
Enterprise Value?$87.2M
Fundamentals ratios updated end of day